Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine if DVS-233 is safe and effective in the treatment of pain and other symptoms of fibromyalgia syndrome.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
NCT07226648 · Fibromyalgia
NCT07358754 · Fibromyalgia
NCT06518278 · Osteoarthritis, Fibromyalgia, and more
NCT06923800 · Fibromyalgia, Irritable Bowel Syndrome
NCT05057676 · Multiple Sclerosis, Clinically Isolated Syndrome, and more
Huntsville, Alabama
Mobile, Alabama
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions